Skip to main navigation
Skip to search
Skip to main content
Uniformed Services University Home
Home
Profiles
Research units
Research output
Projects
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
What's next in the pipeline
F. Vincenti
*
,
A. D. Kirk
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Short survey
›
peer-review
94
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'What's next in the pipeline'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Biological Products
100%
sotrastaurin
97%
2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)-2-hepten-6-ynamide
97%
Transplants
95%
Immunosuppression
92%
Alefacept
86%
efalizumab
83%
tofacitinib
78%
Abatacept
71%
Janus Kinase Inhibitors
71%
Fingolimod Hydrochloride
70%
Clinical Trials
66%
Interleukin-15
64%
Phase II Clinical Trials
61%
Phase III Clinical Trials
61%
United States Food and Drug Administration
50%
Protein Kinase C
48%
Cyclosporine
47%
Industry
46%
Allografts
44%
Protein Isoforms
41%
Immunoglobulin G
38%
Chronic Disease
37%
Monoclonal Antibodies
37%
Research Personnel
35%
Pharmaceutical Preparations
21%
Proteins
18%
Therapeutics
16%